Repair of and checkpoint response to topoisomerase I-mediated DNA damage

被引：244

作者：

Pommier, Y ^{[1
]}

Redon, C ^{[1
]}

Rao, VA ^{[1
]}

Seiler, JA ^{[1
]}

Sordet, O ^{[1
]}

Takemura, H ^{[1
]}

Antony, S ^{[1
]}

Meng, LH ^{[1
]}

Liao, ZY ^{[1
]}

Kohlhagen, G ^{[1
]}

Zhang, HL ^{[1
]}

Kohn, KW ^{[1
]}

机构：

[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | 2003年 / 532卷 / 1-2期

关键词：

topoisomerase; homologous recombination; camptothecin; Tdp1; Mre11; ATM; ATR; BRCA1; BRCA2; RAD52; RAD51; RPA; DNA-PK; cell cycle checkpoints;

D O I：

10.1016/j.mrfmmm.2003.08.016

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Topoisomerase I (Top1) catalyzes two transesterification reactions: single-strand DNA cleavage and religation that are normally coupled for the relaxation of DNA supercoiling in transcribing and replicating chromatin. A variety of endogenous DNA modifications, potent anticancer drugs and carcinogens uncouple these two reactions, resulting in the accumulation of Top I cleavage complexes. Top I cleavage complexes damage DNA and kill cells by generating replication-mediated DNA double-strand breaks (DSBs) and by stalling transcription complexes. The repair of Top1-mediated DNA lesions involves integrated pathways that are conserved from yeasts to humans. Top1-mediated DNA damage and cell cycle checkpoint responses can be studied biochemically and genetically in yeast and human cells with known genetic defects. Defects in these repair/checkpoint pathways, which promote tumor development, explain, at least in part, the selectivity of camptothecins and other Top I inhibitors for cancer cells. (C) 2003 Elsevier B.V. All rights reserved.

引用

页码：173 / 203

页数：31

共 50 条

[41] p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine
T Furuta
R L Hayward
L-H Meng
H Takemura
G J Aune
W M Bonner
M I Aladjem
K W Kohn
Y Pommier
Oncogene, 2006, 25 : 2839 - 2849
[42] A Novel Camptothecin Derivative 3j Inhibits NSCLC Proliferation via Induction of Cell Cycle Arrest by Topo I-Mediated DNA Damage
Liu, Yang
Zhang, Jingyin
Feng, Shuyun
Zhao, Tingli
Li, Zhengzheng
Wang, Lai
Wang, Puhai
Du, Hongzhi
Yuan, Shengtao
Sun, Li
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 365 - 374
[43] P21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine
Furuta, T.
Hayward, R. L.
Meng, L-H
Takemura, H.
Aune, G. J.
Bonner, W. M.
Aladjem, M. I.
Kohn, K. W.
Pommier, Y.
ONCOGENE, 2006, 25 (20) : 2839 - 2849
[44] DNA replication as a target of the DNA damage checkpoint
Zegerman, Philip
Diffley, John F. X.
DNA REPAIR, 2009, 8 (09) : 1077 - 1088
[45] HIV Vpr Modulates the Host DNA Damage Response at Two Independent Steps to Damage DNA and Repress Double-Strand DNA Break Repair
Li, Donna
Lopez, Andrew
Sandoval, Carina
Doyle, Randilea Nichols
Fregoso, Oliver, I
MBIO, 2020, 11 (04): : 1 - 18
[46] Targeting the DNA damage response in pediatric malignancies
Gedminas, Jenna M.
Laetsch, Theodore W.
EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) : 1099 - 1113
[47] The Caenorhabditis elegans Werner syndrome protein participates in DNA damage checkpoint and DNA repair in response to CPT-induced double-strand breaks
Hyun, Moonjung
Choi, Seoyun
Stevnsner, Tinna
Ahn, Byungchan
CELLULAR SIGNALLING, 2016, 28 (03) : 214 - 223
[48] Characterization of DNA Repair Foci in Root Cells of Arabidopsis in Response to DNA Damage
Hirakawa, Takeshi
Matsunaga, Sachihiro
FRONTIERS IN PLANT SCIENCE, 2019, 10
[49] DNA damage repair and response proteins as targets for cancer therapy
Lieberman, Howard B.
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (04) : 360 - 367
[50] DNA damage response and repair in the development and treatment of brain tumors
Dana, Parisa Maleki
Sadoughi, Fatemeh
Mirzaei, Hamed
Asemi, Zatollah
Yousefi, Bahman
EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 924

← 1 2 3 4 5 →